HSDT

Helius Medical Technologies, Inc. [HSDT] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

HSDT Stock Summary

Top 10 Correlated ETFs

HSDT

Top 10 Correlated Stocks

HSDT

In the News

HSDT Financial details

Company Rating
-
Market Cap
5.47M
Income
-7.43M
Revenue
644K
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
22
Optionable
No
Shortable
Yes
Earnings
09 May 2024
P/E
-0.38
Forward P/E
-
PEG
0.05
P/S
6.95
P/B
1.72
P/C
-
P/FCF
-0.52
Quick Ratio
4.99
Current Ratio
5.98
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-11.79
EPS next Y
-
EPS next Q
-
EPS this Y
-68.7%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
-15.51%
Revenue Q/Q
-6.29%
EPS Q/Q
-73.22%
-
-
-
-
SMA20
-66.12%
SMA50
-76.51%
SMA100
-87.56%
Inst Own
-
Inst Trans
-
ROA
-153%
ROE
-249%
ROC
-1.73%
Gross Margin
19%
Oper. Margin
-1623%
Profit Margin
-1715%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
4.29-14.45
52W High
-96.36%
52W Low
-87.28%
RSI
21.76
Rel Volume
21.76
Avg Volume
417.25K
Volume
9.08M
Perf Week
-84.43%
Perf Month
-86.95%
Perf Quarter
-93.04%
Perf Half Y
-94.14%
-
-
-
-
Beta
1.553
-
-
Volatility
0.23%, 1.43%
Prev Close
-15.25%
Price
0.509
Change
-21.09%

Something similar

Top by Market Cap
ABEC.DE
BRYN.DE
VOO
JPM
MIX.JO
Top Correlated ETFs
ZSL
MSOS
CNBS
LABD
MSOX
Top Correlated Stocks
BF-A
BF-B
0HQ3.L
NUWE
WIZZ.L
Similar Market Cap
3LFB.L
SC03.F
HEMB.TO
MCOA
FLYU

Company Profile

Healthcare Medical - Devices
  • Volume Average 417.25K
  • Market Capitalization 5.47M
  • Employee 22
  • CEO Mr. Dane Carl Andreeff
  • Headquarters Newtown,PA,US
  • IPO Date 2014-06-27
  • Website https://heliusmedical.com

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-invasive technologies for the treatment of symptoms caused by neurological disease or trauma. Its product, Portable Neuromodulation Stimulator (PoNS), is a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. The company is headquartered in Newtown, Pennsylvania.